BOPA Introduction to Oncology Course 2019

Are you or someone you know new to oncology?
The British Oncology Pharmacy Association is pleased to announce that our popular Introduction to Oncology Course will be running on the 31st May 2019. 

The one day course is FREE to all BOPA members and will provide a great networking opportunity for people new to working in oncology (less than 2 years’ experience). Expert speakers will present sessions on key topics such as pharmaceutical care planning, oncological emergencies and the latest advances in Personalised Medicine. The full agenda will be published soon. Register early using the link below to secure your place and avoid disappointment!

The Introduction to Oncology course will take place on Friday 31s May 2019 from 08:45 to 16:45 at The Christie School of Oncology, Manchester, United Kingdom

If you are ready to book, please click the link:

https://www.eventbrite.co.uk/e/bopa-introduction-to-oncology-for-pharmacists-tickets-56177653875.

Please note you must be a current member at the time of registration and attendance on the course. Non-members are also welcome at a fee of £100 (including VAT). In the event of late cancellation (within 5 working days) or non-attendance a fee of £50 will be applied.

Not a BOPA member? Why not join for the newcomer rate of £35. Once you are a BOPA member you will have access to our online educational resources and forums, exclusive webinars and study days, plus Annual Symposium discounts.

Latest News

By BOPA Executive Committee on 25th April 2025

NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer at high risk of recurrence in adults.

BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…

Read article
By BOPA IO SAG on 23rd April 2025

Toolkit for Immunotherapy IV to SC switch

Dear all, In the coming months, an increasing number of products traditionally administered intravenously are expected to become available for subcutaneous administration. This shift offers enhanced flexibility for patients; however,…

Read article
By BOPA E&T subcommittee on 17th April 2025

The BOPA Cancer Consultant Pharmacist Credentialing Support Series is back

BOPA are holding a nine month supportive webinar series for pharmacists who are credentialing as consultant pharmacists with the RPS. Join in this relaxed forum to discuss about your portfolio…

Read article
By BOPA research subcommittee on 17th April 2025

Celebration of BOPA member’s recent publications

We are delighted to share that so many of our members have had manuscripts published recently. Here are some that we are aware of but if there are others then…

Read article